Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

George Maynard, Stephen M. Strittmatter, Charles Y. Liu et al.|The Lancet Neurology|2023

Cited by 55